Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis
Open Access
- 1 March 1995
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 77 (6) , 493-504
- https://doi.org/10.1016/0049-3848(95)00025-9
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Plasminogen activators and their inhibitors in non-small cell lung cancer. Low content of type 2 plasminogen activator inhibitor associated with tumor disseminationCancer, 1994
- Expression of tumour necrosis factor‐α in cryptogenic fibrosing alveolitisHistopathology, 1993
- Local activation of the coagulation and fibrinolysis systems in lung diseaseThrombosis Research, 1990
- Monoclonal antibody analysis of purified and cell-associated tissue factorThrombosis Research, 1988
- An ordered addition, essential activation model of the tissue factor pathway of coagulation: evidence for a conformational cageBiochemistry, 1986
- Characterization of various antibodies against tissue plasminogen activator using highly sensitive enzyme immunoassayThrombosis Research, 1986
- Human alveolar macrophages synthesize factor VII in vitro. Possible role in interstitial lung disease.Journal of Clinical Investigation, 1985
- Role of fibronectin as a growth factor for fibroblasts.The Journal of cell biology, 1983
- Natural History and Treated Course of Usual and Desquamative Interstitial PneumoniaNew England Journal of Medicine, 1978
- The Endotoxin‐induced Coagulant Activity of Human MonocytesBritish Journal of Haematology, 1975